Dose-dependent prednisolone kinetics. 1979

A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
April 1986, Clinical pharmacology and therapeutics,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
November 1977, European journal of clinical pharmacology,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
October 1986, The Journal of allergy and clinical immunology,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
August 1989, The Journal of clinical psychiatry,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
November 1978, The Journal of pharmacy and pharmacology,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
August 1981, Journal of pharmacokinetics and biopharmaceutics,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
January 1979, Clinical pharmacokinetics,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
November 1981, Journal of pharmaceutical sciences,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
October 1986, Journal of pharmacokinetics and biopharmaceutics,
A Tanner, and F Bochner, and J Caffin, and J Halliday, and L Powell
January 1983, European journal of clinical pharmacology,
Copied contents to your clipboard!